Michele Yip-Schneider

4.3k citations

83 papers · 2.1k indexed · h-index 27

Molecular Biology top 10%
Oncology top 5%
Cancer Research top 5%
Surgery top 10%
Pharmacology top 5%

Co-authors: C. Max Schmidt Mark S. Marshall Huangbing Wu Amy E. Lin Christopher J. Sweeney Chad Wiesenauer Darlene Barnard Max Schmidt
Topics: Pancreatic and Hepatic Oncology Research (44 papers)Pancreatitis Pathology and Treatment (21 papers)Inflammatory mediators and NSAID effects (12 papers)
Cited by: Cancer Research Oncology Pharmacology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaGastroenterology
Partner nations: United States Russia China

In The Last Decade

Michele Yip-Schneider

77 papers receiving 2.0k citations

Peers

Countries citing papers authored by Michele Yip-Schneider

Since Specialization

Citations

This map shows the geographic impact of Michele Yip-Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Yip-Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Yip-Schneider more than expected).

Fields of papers citing papers by Michele Yip-Schneider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Yip-Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Yip-Schneider. The network helps show where Michele Yip-Schneider may publish in the future.

Co-authorship network of co-authors of Michele Yip-Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Yip-Schneider. A scholar is included among the top collaborators of Michele Yip-Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Yip-Schneider. Michele Yip-Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing 2025 ·Cancer Letters ·Johannes F. Fahrmann,Michele Yip-Schneider,(unknown),(unknown),Jennifer B. Dennison,Kim‐Anh Do,James P. Long,Anirban Maitra,Jianjun Zhang,Charlie Schmidt,Samir Hanash,Ehsan Irajizad	4
2	Cyst fluid proteins stratify malignant risk of intraductal papillary mucinous neoplasm of the pancreas 2025 ·Cancer Letters ·(unknown),Amber L. Mosley,Ehsan Irajizad,Michele Yip-Schneider,Huangbing Wu,(unknown),(unknown),James P. Long,Kim‐Anh Do,Johannes F. Fahrmann,John M. DeWitt,Samir Hanash,C. Max Schmidt,Jianjun Zhang	0
3	Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progression 2025 ·Clinical Cancer Research ·(unknown),Yihui Chen,Rongzhang Dou,Ehsan Irajizad,Michele Yip-Schneider,Ranran Wu,(unknown),(unknown),Yaxi Li,(unknown),Riccardo Ballarò,Jody V. Vykoukal,Mark W. Hurd,Jennifer B. Dennison,Kim‐Anh Do,Anirban Maitra,Jianjun Zhang,Samir Hanash,C. Max Schmidt,Johannes F. Fahrmann	0
4	Potential Health Disparities in the Early Detection and Prevention of Pancreatic Cancer 2024 ·Cureus ·Michele Yip-Schneider,(unknown),(unknown),(unknown),(unknown),(unknown),Alexandra M. Roch,(unknown)	2
5	Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential 2023 ·Cancer Discovery ·Marta Sans,Yuki Makino,Jimin Min,Kimal Rajapakshe,Michele Yip-Schneider,C. Max Schmidt,Mark W. Hurd,Jared K. Burks,Javier A. Gomez,Fredrik I. Thege,Johannes F. Fahrmann,Robert A. Wolff,Michael P. Kim,Paola A. Guerrero,Anirban Maitra	27
6	EUS-guided fine needle aspiration-based clues to mistaken or uncertain identity: serous pancreatic cysts 2023 ·HPB ·Michele Yip-Schneider,(unknown),(unknown),Howard H. Wu,Stuart Sherman,(unknown),Mohammad Al‐Haddad,John M. DeWitt,C. Max Schmidt	1
7	A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm Dysplasia 2020 ·Pancreas ·(unknown),Michele Yip-Schneider,(unknown),Rachel E. Simpson,Cameron L. Colgate,Huangbing Wu,(unknown),John M. DeWitt,Amber L. Mosley,Eugene P. Ceppa,Jianjun Zhang,C. Max Schmidt	3
8	Insurance Type and Marital Status Impact Hospital Length of Stay After Pancreatoduodenectomy 2020 ·Journal of Surgical Research ·(unknown),(unknown),Michele Yip-Schneider,Thomas K. Maatman,Cameron L. Colgate,(unknown),(unknown),C. Max Schmidt	6
9	Comparison of skin closure techniques in patients undergoing open pancreaticoduodenectomy: A single center experience 2020 ·The American Journal of Surgery ·(unknown),Rachel E. Simpson,(unknown),(unknown),Michele Yip-Schneider,Cameron L. Colgate,Eugene P. Ceppa,Michael G. House,Nicholas J. Zyromski,Attila Nakeeb,(unknown)	3
10	Performance of candidate urinary biomarkers for pancreatic cancer - Correlation with pancreatic cyst malignant progression? 2019 ·The American Journal of Surgery ·Michele Yip-Schneider,(unknown),Rosalie A. Carr,(unknown),Huangbing Wu,Cameron L. Colgate,C. Max Schmidt	6
11	Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia 2019 ·Pancreas ·Rachel E. Simpson,Michele Yip-Schneider,(unknown),Huangbing Wu,Cameron L. Colgate,C. Max Schmidt	15
12	Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts 2017 ·Clinical Cancer Research ·(unknown),Jeremy Sharib,Dana A. Dominguez,Nilotpal Roy,(unknown),Michele Yip-Schneider,C. Max Schmidt,Randall E. Brand,Walter G. Park,Matthias Hebrok,Grace Kim,Anthony J. O’Donoghue,Kimberly S. Kirkwood,Charles S. Craik	31
13	Tailored α-methylene-γ-butyrolactones and their effects on growth suppression in pancreatic carcinoma cells 2010 ·Bioorganic & Medicinal Chemistry Letters ·P. Veeraraghavan Ramachandran,Debarshi Pratihar,Hari Nair,Matthew J. Walters,Sadie Smith,Michele Yip-Schneider,Huangbing Wu,C. Max Schmidt	25
14	Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers 2010 ·BMC Cancer ·Zhaomin Li,Zizheng Dong,David L. Myer,Michele Yip-Schneider,Jianguo Liu,Ping Cui,C. Max Schmidt,Jian‐Ting Zhang	40
15	Targeting mitogen‐activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems† 2009 ·Hepatology ·(unknown),Michele Yip-Schneider,(unknown),Huangbing Wu,S. K. Hekmatyar,Patrick Klein,Navin Bansal,C. Max Schmidt	28
16	The Role of Nuclear Factor κB in Pancreatic Cancer and the Clinical Applications of Targeted Therapy 2008 ·Pancreas ·(unknown),Michele Yip-Schneider,(unknown)	76
17	Sulindac Prevents Carcinogen-Induced Intrahepatic Cholangiocarcinoma Formation In Vivo 2008 ·Journal of Surgical Research ·(unknown),Michele Yip-Schneider,Earl A. Gage,Romil Saxena,Sunil Badve,C. Max Schmidt	7
18	The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer 2006 ·Neoplasia ·Patrick Klein,C. Max Schmidt,Chad Wiesenauer,Jennifer Choi,Earl A. Gage,Michele Yip-Schneider,Eric A. Wiebke,Yufang Wang,Charles A. Omer,Judith S. Sebolt–Leopold	59
19	Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model 2006 ·The Prostate ·Rajasubramaniam Shanmugam,(unknown),Yesim Gökmen‐Polar,Stephanie L. Kelich,Kathy D. Miller,Michele Yip-Schneider,Liang Cheng,Poornima Bhat‐Nakshatri,George W. Sledge,Harikrishna Nakshatri,Qi-Huang Zheng,Michael A. Miller,Timothy R. DeGrado,Gary D. Hutchins,Christopher J. Sweeney	43
20	Inhibition of the Phosphatidylinositol 3′–Kinase Signaling Pathway Increases the Responsiveness of Pancreatic Carcinoma Cells to Sulindac 2003 ·Journal of Gastrointestinal Surgery ·Michele Yip-Schneider,Chad Wiesenauer,C. Max Schmidt	24

About Michele Yip-Schneider

Michele Yip-Schneider is a scholar working on Oncology, Toxicology and Cancer Research, having authored 83 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (44 papers), Pancreatitis Pathology and Treatment (21 papers) and Inflammatory mediators and NSAID effects (12 papers). The work is most often cited by research in Cancer Research (574 citations), Oncology (832 citations) and Pharmacology (324 citations). Michele Yip-Schneider has collaborated with scholars based in United States, Russia and China. Frequent co-authors include C. Max Schmidt, Mark S. Marshall, Huangbing Wu, Amy E. Lin, Christopher J. Sweeney, Chad Wiesenauer, Darlene Barnard, Max Schmidt, Yufang Wang and Eric A. Wiebke. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact